Daily news email for June 27, 2012 | Click here for updated news
Biotechnology - Moreover Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report Celgene Withdraws EU Application for Revlimid
Celgene Withdraws EU Application for Revlimed
BGI and Hospital Plan to Sequence 1,000 Rare Diseases
BIO Study: Bayh-Dole Shows Big Returns
The Biotech Story You Wont Read in your Local Newspaper
|
CenterWatch - Clinical Trials Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|